CA2312528A1 - Composition cosmetique raffermissante comprenant au moins un hydroxystilbene en association avec de l'acide ascorbique - Google Patents

Composition cosmetique raffermissante comprenant au moins un hydroxystilbene en association avec de l'acide ascorbique Download PDF

Info

Publication number
CA2312528A1
CA2312528A1 CA002312528A CA2312528A CA2312528A1 CA 2312528 A1 CA2312528 A1 CA 2312528A1 CA 002312528 A CA002312528 A CA 002312528A CA 2312528 A CA2312528 A CA 2312528A CA 2312528 A1 CA2312528 A1 CA 2312528A1
Authority
CA
Canada
Prior art keywords
hydroxystilbene
ascorbic acid
cosmetic
association
compound containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002312528A
Other languages
English (en)
Other versions
CA2312528C (fr
Inventor
Lionel Breton
Christel Liviero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of CA2312528A1 publication Critical patent/CA2312528A1/fr
Application granted granted Critical
Publication of CA2312528C publication Critical patent/CA2312528C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention se rapporte à une composition comprenant au moins un hydroxystilbène en association avec de l'acide ascorbique. La composition es t particulièrement une composition cosmétique raffermissante.
CA002312528A 1999-07-02 2000-06-27 Composition cosmetique raffermissante comprenant au moins un hydroxystilbene en association avec de l'acide ascorbique Expired - Lifetime CA2312528C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908570A FR2795643B1 (fr) 1999-07-02 1999-07-02 Composition cosmetique raffermissante comprenant au moins un hydroxystilbene en association avec de l'acide ascorbique
FR9908570 1999-07-02

Publications (2)

Publication Number Publication Date
CA2312528A1 true CA2312528A1 (fr) 2001-01-02
CA2312528C CA2312528C (fr) 2006-05-16

Family

ID=9547655

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002312528A Expired - Lifetime CA2312528C (fr) 1999-07-02 2000-06-27 Composition cosmetique raffermissante comprenant au moins un hydroxystilbene en association avec de l'acide ascorbique

Country Status (8)

Country Link
US (2) US6440433B1 (fr)
EP (1) EP1064931B1 (fr)
JP (1) JP2001048722A (fr)
AT (1) ATE284671T1 (fr)
CA (1) CA2312528C (fr)
DE (1) DE60016670T2 (fr)
ES (1) ES2234537T3 (fr)
FR (1) FR2795643B1 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
FR2811568B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un agent anti-glycation
FR2818139B1 (fr) * 2000-12-15 2003-02-14 Oreal Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un agent anti-glycation
ITMI20010528A1 (it) * 2001-03-13 2002-09-13 Istituto Biochimico Pavese Pha Complessi di resveratrolo con fosfolipidi loro preparazione e composizioni farmaceutiche e cosmetiche
WO2003010121A1 (fr) * 2001-07-23 2003-02-06 Pacific Corporation Derives de stilbene, procede de preparation correspondant et utilisation correspondante
US7482314B2 (en) * 2002-07-11 2009-01-27 Orchid Scientific, Inc. Microdermabrasion composition and kit
US7977049B2 (en) 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
FR2844714B1 (fr) * 2002-09-20 2007-04-27 Af Consulting Compositions pour les soins de la peau subissant un desequilibre hormonal, et contenant un ou des oligomeres de resveratrol, en particulier de l'epsilone-viniferine, et/ou certains de leurs derives
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
ES2219166B1 (es) * 2003-02-20 2006-02-16 Victor Casaña Giner Combinacion antioxidante sinergistica a base de resveratrol.
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
WO2005002672A2 (fr) * 2003-07-01 2005-01-13 President And Fellows Of Harvard College Compositions pour la manipulation de la duree de vie et de la reaction de stress de cellules et d'organismes
US20060025337A1 (en) * 2003-07-01 2006-02-02 President And Fellows Of Harvard College Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
FR2862533B1 (fr) * 2003-11-21 2006-04-28 Oreal Utilisation cosmetique d'au moins un activateur de la production d'une interleukine 11, comme agent amincissant topique
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
AU2004312072B2 (en) 2003-12-29 2011-06-23 President And Fellows Of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
DK2233127T3 (da) 2004-03-17 2020-08-24 Stada Arzneimittel Ag Anvendelse af antioxidanter til fremstilling af en farmaceutisk eller kosmetisk sammensætning for at beskytte huden mod skader som følge af infrarød stråling
FR2867977B1 (fr) * 2004-03-26 2013-04-12 Af Consulting Compositions pour limiter les rides de la peau provoquees par les contractions des muscles sous-cutanes et contenant du resveratrol et/ou de ses derives
JP4620960B2 (ja) * 2004-03-29 2011-01-26 株式会社ナリス化粧品 イタドリ根抽出物の精製法及びその精製物を含有する化粧料
WO2006007411A2 (fr) * 2004-06-16 2006-01-19 President And Fellows Of Harvard College Methodes et compositions pour moduler une apoptose mediee par bax
WO2006004722A2 (fr) * 2004-06-30 2006-01-12 Biomol Research Laboratories, Inc. Compositions et methodes permettant d'activer selectivement des sirtuines humaines
WO2006138418A2 (fr) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Amelioration de la performance cognitive avec des activateurs de sirtuine
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20070048246A1 (en) * 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
MX2008010716A (es) 2006-02-21 2008-10-14 Mary Kay Inc Composiciones estables de vitamina c.
JP2008105983A (ja) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd 線維芽細胞増殖促進剤、皮膚外用剤、浴用剤及び飲食物
JP2008105985A (ja) * 2006-10-25 2008-05-08 Nicca Chemical Co Ltd ヒアルロン酸産生促進剤、皮膚外用剤、浴用剤及び飲食物
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
KR100843155B1 (ko) 2006-11-30 2008-07-02 인오투(주) 이중으로 안정화된 비타민씨 함유 피부 미백 화장료 조성물
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
US8344024B2 (en) * 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
US20090035236A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US9295621B2 (en) * 2007-07-31 2016-03-29 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
US8080583B2 (en) 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009032896A2 (fr) * 2007-09-08 2009-03-12 Elc Management Llc Composés de férulate de resvératrol, compositions contenant lesdits composés et leurs procédés d'utilisation
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
WO2010041141A2 (fr) 2008-10-07 2010-04-15 Foamix Ltd. Support expansible à base d’huile et préparations
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
EP2242476A2 (fr) 2008-01-14 2010-10-27 Foamix Ltd. Compositions pharmaceutiques pouvant mousser de poloxamère avec des agents actifs et/ou des cellules thérapeutiques, et utilisations
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
FR2946529B1 (fr) * 2009-06-10 2011-09-09 Lvmh Rech Utilisation d'un extrait de cereale, en tant qu'agent actif amincissant dans une composition cosmetique amincissante
WO2011013008A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes à base d'agents non tensioactifs non polymères, mousses légères, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
JP2011046660A (ja) * 2009-08-28 2011-03-10 Fujifilm Corp マトリックスメタロプロテアーゼ−２（ｍｍｐ−２）阻害剤
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
US9144564B2 (en) * 2013-03-21 2015-09-29 Julius Zecchino Delivery system having stabilized ascorbic acid and other actives
FR3017289B1 (fr) * 2014-02-07 2017-05-05 Caudalie Composition a fort pouvoir antioxydant a base de derives de polyohenols et application en cosmetique
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
TWI722443B (zh) 2019-05-30 2021-03-21 財團法人工業技術研究院 用於照護及/或保養皮膚與延緩及/或抑制皮膚老化的生醫組成物及其用途
CN110638686B (zh) * 2019-10-30 2021-10-26 华南理工大学 一种抑制色斑、抗皮肤光老化作用的护肤组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784847A (en) * 1987-04-28 1988-11-15 Zulliger Bopp Monika G Wine-containing skin-care products
JPH08175960A (ja) * 1994-12-27 1996-07-09 Kao Corp シワ予防用化粧料
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
GB2317561B (en) * 1996-09-20 2000-12-06 Howard Foundation Improvements in or relating to food supplements
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US6124348A (en) * 1997-07-01 2000-09-26 Lawrence M. Wells Vitamin C skin formulations
US6270780B1 (en) * 1997-07-25 2001-08-07 Chesebrough-Pond's Usa Co., Division Of Conopco Cosmetic compositions containing resveratrol
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
FR2777183B1 (fr) * 1998-04-10 2001-03-02 Oreal Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant

Also Published As

Publication number Publication date
EP1064931B1 (fr) 2004-12-15
FR2795643A1 (fr) 2001-01-05
US6753000B2 (en) 2004-06-22
FR2795643B1 (fr) 2004-06-11
US6440433B1 (en) 2002-08-27
ATE284671T1 (de) 2005-01-15
EP1064931A1 (fr) 2001-01-03
JP2001048722A (ja) 2001-02-20
DE60016670T2 (de) 2005-09-15
ES2234537T3 (es) 2005-07-01
DE60016670D1 (de) 2005-01-20
CA2312528C (fr) 2006-05-16
US20030031693A1 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
CA2312528A1 (fr) Composition cosmetique raffermissante comprenant au moins un hydroxystilbene en association avec de l'acide ascorbique
CA2164050A1 (fr) Compositions cosmetiques renfermant de l'acide betulinique
AU3415297A (en) Thickened personal care composition
MY128838A (en) Oral composition
GR950100229A (en) Insulin analog formulations.
AU4462093A (en) Viscoelastic personal care composition
AU5739994A (en) Oral compositions containing antiplaque, anticalculus agents
AU2642195A (en) Antimicrobial cleaning composition containing chlorhexidine, anamphoteric and an alkylpolyglucoside
AU1052492A (en) Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
AU1375799A (en) Alignment indicators for use with personal care articles
AU4725793A (en) Schwann cell mitogenic factor, its preparation and use
AU3840395A (en) Personal care composition
NZ315769A (en) Lioposomal composition containing hepatocyte growth factor (hgf)
EP0799578A3 (fr) Préparation combinée comprenant des germes enrichis en électrolytes
AU7309394A (en) Disinfectant composition
AU3480297A (en) Modified mcm-56, its preparation and use
EP0747768A3 (fr) Composition chimiquement amplifiée pour réserve positive
AU6388494A (en) Skin care composition
AU6611894A (en) Cosmetic composition containing, in combination, a superoxide-dismutase and a melanin pigment
CA2230159A1 (fr) Utilisation de composes d'aminoadamantane en tant qu'immunoregulateurs
AU4667396A (en) Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
AU2100997A (en) Composition containing iso-flavonoids and lignans
CA2254413A1 (fr) Compositions de teinture
HU9402648D0 (en) 3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine composition containing them as active componens

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20200629